By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The US Food and Drug Administration has reopened its comment period for the public and stakeholders to respond to its oversight plans for laboratory-developed tests until September 15.

FDA reopened the comment period, which initially closed on August 15, because it had received requests from stakeholders who wanted more time to develop or provide their opinions and recommendations on the issue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.